Mabwell (Shanghai) Bioscience Co., Ltd.

Mabwell (Shanghai) Bioscience Co., Ltd. is a biopharmaceutical company primarily focused on the research, development, and manufacturing of innovative and biosimilar drugs. With a commitment to advancing healthcare, Mabwell develops therapies for a range of autoimmune disorders, cancers, and infectious diseases. By utilizing a robust platform of cutting-edge biotechnology, the company significantly contributes to the development of monoclonal antibodies and recombinant proteins. As part of its broad therapeutic portfolio, Mabwell engages with various sectors of the healthcare industry, including pharmaceuticals and biotechnology enterprises, to enhance its drug discovery and development processes. Established in China's bustling biotech hub of Shanghai, Mabwell plays a pivotal role in the local and global pharmaceutical landscape, pushing the boundaries of innovation in treatment modalities and contributing significantly to the healthcare sector's growth. Through its collaborations and strategic partnerships, Mabwell endeavors to deliver high-quality medicinal products, meeting unmet medical needs and improving patient outcomes worldwide.